{
  "id": 6630,
  "language": "english",
  "hallucination": "yes",
  "ground_truth_source": "Original_text",
  "dialogue_data": {
    "dialogue_metadata": {
      "inferred_relationship": "Co-hosts",
      "inferred_vibe": "Informative and concerned"
    },
    "dialogue_turns": [
      {
        "speaker": "HostA",
        "text": "Back in 1993, a quarter-century of effort has yielded surprisingly few new TB medicines. And since then, 250 million people have been infected—millions have died. They deserved better options.",
        "tts_text": "Back in nineteen ninety three, a quarter-century of effort has yielded surprisingly few new T B medicines. And since then, two hundred fifty million people have been infected-millions have died. They deserved better options.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "But while leaders generally agree on the need to invest in solutions, we have surprisingly few TB medicines to show for our quarter-century of effort. The 250 million people who have been infected since 1993 and the millions who have died deserved better.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "It's just staggering, you know? TB is still the world's deadliest infection, and it's ancient—like, researchers think it started in Africa around 5,200 years ago.",
        "tts_text": "It's just staggering, you know? T B is still the world's deadliest infection, and it's ancient-like, researchers think it started in Africa around five thousand, two hundred years ago.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Researchers theorize that humans first acquired TB in Africa about 5,000 years ago, and that the disease then swiftly spread along trade routes to nearly every corner of the globe.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Right, and now we're seeing drug-resistant strains becoming more common, which is uh, really worrying.",
        "tts_text": "Right, and now we're seeing drug-resistant strains becoming more common, which is uh, really worrying.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "But the effectiveness of TB treatments is declining, raising concerns that drug-resistant strains are becoming more virulent.",
        "confidence": 0.9,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Yeah, and the economic impact is huge too. By 2051, drug-resistant TB could cost the global economy up to $17.2 trillion.",
        "tts_text": "Yeah, and the economic impact is huge too. By twenty fifty one, drug-resistant T B could cost the global economy up to seventeen point two dollars trillion.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "By 2050, drugresistant TB could cost the global economy as much as $16.7 trillion in medical expenses and lost wages roughly the equivalent of the European Unions entire economic output.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "That's almost the EU's entire economic output—just wiped out by one disease.",
        "tts_text": "That's almost the E U's entire economic output-just wiped out by one disease.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "By 2050, drugresistant TB could cost the global economy as much as $16.7 trillion in medical expenses and lost wages roughly the equivalent of the European Unions entire economic output.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "But there is some progress, right? Researchers are working on better drugs, diagnostics, vaccines…",
        "tts_text": "But there is some progress, right? Researchers are working on better drugs, diagnostics, vaccines...",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Researchers are closing in on more effective drug regimens, better diagnostics tools, and viable vaccines.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "True, but the funding gap is massive. The WHO says there's a $1.4 billion annual deficit in R&D.",
        "tts_text": "True, but the funding gap is massive. The W H O says there's a one point four dollars billion annual deficit in R&D.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "According to the World Health Organization, the annual funding deficit for TB research and development is more than $1.3 billion, a shortfall that is exacerbated by a lack of market incentives within the pharmaceutical industry.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "And two-thirds of new cases are in just eight countries—India, China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, South Africa.",
        "tts_text": "And two-thirds of new cases are in just eight countries-India, China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, South Africa.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Despite TBs global reach, two-thirds of new cases in 2017 occurred in just eight countries India, China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "So the burden isn't evenly distributed, and neither is the research investment. Pharma companies aren't jumping in on their own.",
        "tts_text": "So the burden isn't evenly distributed, and neither is the research investment. Pharma companies aren't jumping in on their own.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "With drug makers apparently unwilling or unable to fund development costs unilaterally, rich and poor countries must collaborate to fill the gap.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Which means public and private sectors have to collaborate. We can't just rely on market incentives here.",
        "tts_text": "Which means public and private sectors have to collaborate. We can't just rely on market incentives here.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The R&D burden must be shared among the public and private sectors, and resulting treatments must be universally adopted and available.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Exactly. And treatments have to be accessible and affordable—especially for high-risk groups like health workers or people with HIV.",
        "tts_text": "Exactly. And treatments have to be accessible and affordable-especially for high-risk groups like health workers or people with H I V.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The goal should be to ensure that medicines are accessible and affordable for anyone who needs them; this includes high-risk populations such as health-care workers, as well as people living with HIV/AIDS, for whom TB is a leading cause of death.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Remember that UN meeting back in September? There was all that debate over intellectual property rights…",
        "tts_text": "Remember that U N meeting back in September? There was all that debate over intellectual property rights...",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The high-level meeting in September was meant to galvanize the worlds TB-eradication efforts. Unfortunately, the rare political unity in the lead-up to the discussion was overshadowed by a debate about drug makers intellectual-property rights.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Yeah, it kinda overshadowed the real issue—how do we fund R&D while making sure the poorest patients get treatment?",
        "tts_text": "Yeah, it kinda overshadowed the real issue-how do we fund R&D while making sure the poorest patients get treatment?",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "While the declaration endorsed at the end of the UN meeting did offer a compromise, the quandary remains: how can we guarantee access to medications especially for the poorest patients while maintaining funding streams for pharmaceutical R&D?",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "It's a tough balance. But we've got to act fast—3.5 million people didn't get treatment last year alone.",
        "tts_text": "It's a tough balance. But we've got to act fastminus three point five million people didn't get treatment last year alone.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Last year, an estimated 3.6 million people infected with TB were unable to access treatment, a staggering gap in coverage that must be quickly closed.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "The death toll's just going to keep climbing if we don't step up funding and collaboration now.",
        "tts_text": "The death toll's just going to keep climbing if we don't step up funding and collaboration now.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The longer we wait to increase R&D funding and strengthen collaboration on treatment, the higher TBs death toll will climb.",
        "confidence": 1.0,
        "priority": "high"
      }
    ]
  },
  "generator_model": "DeepSeek-V3.1",
  "batch_index": 2
}